ETNB - 89bio Inc
14.84
0 0%
Share volume: 55,645,393
Last Updated: 10-29-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$14.84
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-09-2024 | 08-05-2024 | 11-07-2024 | 02-27-2025 | 05-02-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | ||||
| Operating expenses | 57.277 M | 53.436 M | 151.938 M | 122.005 M | 75.909 M | |
| Selling general and admin | 9.849 M | 8.571 M | 10.497 M | 10.702 M | 11.515 M | |
| Research and development | 47.428 M | 44.865 M | 141.441 M | 111.303 M | 64.394 M | |
| Total expenses | 57.277 M | 53.436 M | 151.938 M | 122.005 M | 75.909 M | |
| -6.71% | 184.34% | -19.70% | -37.78% | |||
| Operating income | -57.277 M | -53.436 M | -151.938 M | -122.005 M | -75.909 M | |
| Ebit | -50.721 M | -46.963 M | -146.507 M | -116.906 M | -69.871 M | |
| Pretax income | -51.584 M | -47.837 M | -148.869 M | -118.097 M | -71.138 M | |
| -7.26% | 211.20% | -20.67% | -39.76% | |||
| Income tax | 97.000 K | 134.000 K | 204.000 K | 257.000 K | 137.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -51.681 M | -47.971 M | -149.073 M | -118.354 M | -71.275 M | |
| 7.18% | -210.76% | 20.61% | 39.78% |